Alzchem Group AG receives strong support from shareholders at Annual General
Meeting; dividend increase to EUR 1.20 per share approved

EQS-News: Alzchem Group AG / Key word(s): AGM/EGM
Alzchem Group AG receives strong support from shareholders at Annual General
Meeting; dividend increase to EUR 1.20 per share approved

07.05.2024 / 16:21 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Alzchem Group AG receives strong support from shareholders at Annual General
Meeting; dividend increase to EUR 1.20 per share approved

Trostberg, May 7, 2024 - At today's virtual Annual General Meeting, the
Management Board and Supervisory Board once again received strong approval
from the shareholders of Alzchem Group AG for their direction of the
company. All items on the agenda were resolved by a large majority as
proposed by the management. Particularly noteworthy is the increase in the
dividend to EUR 1.20 per share (previous year: EUR 1.05), which was made
possible by Alzchem's strong earnings performance in the fiscal year 2023.
The plenary session also approved the discharge of the Management Board and
Supervisory Board, the appointment of the auditor for the annual and
consolidated financial statements for 2024 and the sustainability report for
2024, the remuneration report, the authorization to acquire and use treasury
shares as well as an amendment to the articles of association.

Andreas Niedermaier, CEO of Alzchem Group AG: "The extraordinarily high
level of approval from our shareholders for all items on the agenda confirms
the successful development and strategy of Alzchem. Our consistent
transformation to specialty chemicals has proven itself impressively in 2023
and enables us to allow our shareholders to participate in Alzchem's success
in the form of a significantly increased dividend. We also expect sustained
profitable growth in the coming years."

The detailed voting results for the individual items on the agenda of the
Annual General Meeting can be downloaded from the company website at
https://www.alzchem.com/en/investor-relations/annual-general-meeting/.

About Alzchem

Alzchem is a globally active specialty chemicals company that is one of the
market leaders in most of its fields of activity. Alzchem benefits from the
three very different global developments climate change, population growth
and longer life expectancy in a unique way. Alzchem products can offer
attractive solutions for achieving the resulting social goals in a multitude
of different applications.

The company sees interesting growth prospects for itself in the areas of
human and animal nutrition and agriculture in particular. As a result of
population growth, it is necessary to achieve efficient food production.
Pharmaceutical raw materials and creatine products can contribute to a
healthy old age as life expectancy increases.

Alzchem is facing up to the goal of sustainability arising from climate
change in the field of renewable energies and across the entire company. The
fields of fine chemicals and metallurgy offer just as great a perspective.

Alzchem Group AG's broad product range includes dietary supplements,
precursors for PCR tests and pharmaceutical raw materials. These offerings
are the company's response to global trends and developments. Alzchem is
ideally positioned in this respect and considers itself well prepared for an
environmental future and global developments.

The company employs around 1,690 people at four production sites in Germany
and a plant in Sweden, as well as three sales companies in the USA, China
and England. Alzchem generated Group sales of EUR 540.6 million and EBITDA
of EUR 81.4 million in 2023.


---------------------------------------------------------------------------

07.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        Alzchem Group AG
                   Dr.-Albert-Frank-Str. 32
                   83308 Trostberg
                   Germany
   Phone:          +498621862888
   Fax:            +49862186502888
   E-mail:         ir@alzchem.com
   Internet:       www.alzchem.com
   ISIN:           DE000A2YNT30
   WKN:            A2YNT3
   Listed:         Regulated Market in Frankfurt (Prime Standard);
                   Regulated Unofficial Market in Stuttgart
   EQS News ID:    1897891

End of News EQS News Service
---------------------------------------------------------------------------

1897891 07.05.2024 CET/CEST